|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0017262,
umls-concept:C0023418,
umls-concept:C0059438,
umls-concept:C0086418,
umls-concept:C0185117,
umls-concept:C0600432,
umls-concept:C1173600,
umls-concept:C1280500,
umls-concept:C1337109,
umls-concept:C1512310,
umls-concept:C1521761,
umls-concept:C2911684
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2008-2-5
|
|
pubmed:abstractText |
To study the expression of X-linked inhibitor of apoptosis protein (XIAP)-associated factor 1 (Xaf1) in human leukemia HL-60 and K562 cells treated with interferon alpha (INFalpha) and the demethylating agent 5-AZA-CdR, and observe the synergetic antitumor effect of Xaf1 inducer and (-)-epigallocatechin-3-gallate (EGCG).
|
|
pubmed:language |
chi
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anticarcinogenic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic,
http://linkedlifedata.com/resource/pubmed/chemical/Azacitidine,
http://linkedlifedata.com/resource/pubmed/chemical/Catechin,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Intracellular Signaling Peptides...,
http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/X-Linked Inhibitor of Apoptosis...,
http://linkedlifedata.com/resource/pubmed/chemical/XAF1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/bcl-2-Associated X Protein,
http://linkedlifedata.com/resource/pubmed/chemical/epigallocatechin gallate
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1673-4254
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
204-8
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18250043-Anticarcinogenic Agents,
pubmed-meshheading:18250043-Antimetabolites, Antineoplastic,
pubmed-meshheading:18250043-Apoptosis,
pubmed-meshheading:18250043-Azacitidine,
pubmed-meshheading:18250043-Catechin,
pubmed-meshheading:18250043-Drug Synergism,
pubmed-meshheading:18250043-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:18250043-HL-60 Cells,
pubmed-meshheading:18250043-Humans,
pubmed-meshheading:18250043-Interferon-alpha,
pubmed-meshheading:18250043-Intracellular Signaling Peptides and Proteins,
pubmed-meshheading:18250043-K562 Cells,
pubmed-meshheading:18250043-Neoplasm Proteins,
pubmed-meshheading:18250043-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:18250043-RNA, Messenger,
pubmed-meshheading:18250043-Up-Regulation,
pubmed-meshheading:18250043-X-Linked Inhibitor of Apoptosis Protein,
pubmed-meshheading:18250043-bcl-2-Associated X Protein
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
[Effect of (-)-epigallocatechin-3-gallate and 5-AZA-CdR on expression of X-linked inhibitor of apoptosis protein-associated factor 1 in human leukemia HL-60 and K562 cells].
|
|
pubmed:affiliation |
Department of Pediatrics, College of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, China. yyhuang586@126.com
|
|
pubmed:publicationType |
Journal Article,
English Abstract,
Research Support, Non-U.S. Gov't
|
